Rigrodsky & Long, P.A.:
  • Do you own shares of Impax Laboratories, Inc. (NASDAQ GS: IPXL )?
  • Did you purchase any of your shares prior to October 17, 2017?
  • Do you think the proposed buyout is fair?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Impax Laboratories, Inc. ("Impax" or the "Company") (NASDAQ GS: IPXL) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Amneal Pharmaceuticals LLC ("Amneal"). Under the terms of the agreement, shareholders of Impax will own approximately 25% of the new company's pro forma shares on an as converted basis.

If you own common stock of Impax and purchased any shares before October 17, 2017, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242, or by e-mail at info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities fraud, shareholder corporate, and shareholder derivative litigation on behalf of shareholders in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171127006056/en/

Copyright Business Wire 2010